Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003320
Filing Date
2015-05-05
Accepted
2015-05-05 17:10:59
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20150331.htm 10-Q 773850
2 EX-31.1 srne-ex311_201503319.htm EX-31.1 9574
3 EX-31.2 srne-ex312_201503317.htm EX-31.2 9495
4 EX-32.1 srne-ex321_201503318.htm EX-32.1 10893
  Complete submission text file 0001564590-15-003320.txt   4934000

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20150331.xml EX-101.INS 650725
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20150331.xsd EX-101.SCH 38611
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20150331_cal.xml EX-101.CAL 41436
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20150331_def.xml EX-101.DEF 123858
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20150331_lab.xml EX-101.LAB 308306
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20150331_pre.xml EX-101.PRE 233582
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 15833985
SIC: 8731 Services-Commercial Physical & Biological Research